High-Throughput Screening for Tuberculosis Progression Using Zebrafish
Author Information
Author(s): Ralph Carvalho, Jan de Sonneville, Oliver W. Stockhammer, Nigel D. L. Savage, Wouter J. Veneman, Tom H. M. Ottenhoff, Ron P. Dirks, Annemarie H. Meijer, Herman P. Spaink
Primary Institution: ZF-screens B.V., Leiden, The Netherlands
Hypothesis
Can a high-throughput screening system using zebrafish effectively model tuberculosis progression and test anti-tuberculosis compounds?
Conclusion
The developed high-throughput system using zebrafish can effectively model tuberculosis progression and test the efficacy of anti-tuberculosis drugs.
Supporting Evidence
- The zebrafish model mimics human tuberculosis pathology, allowing for effective drug testing.
- The automatic injector achieved a throughput of 2,000 embryos per hour.
- Zebrafish larvae showed similar disease symptoms to those observed in human tuberculosis.
- Drug treatment significantly reduced bacterial load in treated zebrafish compared to untreated ones.
Takeaway
Researchers created a new way to study tuberculosis using tiny fish called zebrafish, which helps them test new medicines quickly and easily.
Methodology
The study involved developing an automatic injection system for zebrafish embryos to test the progression of tuberculosis and the efficacy of drugs.
Limitations
The study primarily focuses on the zebrafish model, which may not fully replicate human tuberculosis pathology.
Participant Demographics
Zebrafish embryos were used as the model organism.
Statistical Information
P-Value
0.0004
Statistical Significance
p=0.0004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website